SMARCB1/INI1 inactivation in renal medullary carcinoma

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

(2011) F. Bourdeaut et al.   CLINICAL CANCER RESEARCH

The role of SMARCB1/INI1 in the development of rhabdoid tumors

(2010) Charles Roberts et al.   CANCER BIOLOGY & THERAPY

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

(2010) Adrián Mariño-Enríquez et al.   GENES CHROMOSOMES & CANCER

Epithelioid Sarcoma

(2009) Laila Chbani et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy

(2009) Edward M. Schaeffer et al.   BJU INTERNATIONAL

Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

(2009) Uta Flucke et al.   HUMAN PATHOLOGY

Uncommon and recently described renal carcinomas

(2009) John R Srigley et al.   MODERN PATHOLOGY

The SWI/SNF complex and cancer

(2009) D Reisman et al.   ONCOGENE

Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

(2008) Kenichi Kohashi et al.   HUMAN PATHOLOGY

Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior

(2008) Jason X Cheng et al.   MODERN PATHOLOGY

Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability

(2008) E. S. McKenna et al.   MOLECULAR AND CELLULAR BIOLOGY